As CCL5 was unable to promote migration of LNCaP siAR cells, it was concluded that elevated CCL5 secretion by bone stromal cells from metastatic lesions induced prostate cancer cell migration in a CCL5-dependent manner, upstream of AR signaling [12]. The gene discussed is CCL5; the disease is prostate cancer.